These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8801209)

  • 1. p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis.
    Rizzi PM; Ryder SD; Portmann B; Ramage JK; Naoumov NV; Williams R
    Gut; 1996 Feb; 38(2):265-8. PubMed ID: 8801209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development.
    Boberg KM; Schrumpf E; Bergquist A; Broomé U; Pares A; Remotti H; Schjölberg A; Spurkland A; Clausen OP
    J Hepatol; 2000 Mar; 32(3):374-80. PubMed ID: 10735605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
    Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
    J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis.
    Batheja N; Suriawinata A; Saxena R; Ionescu G; Schwartz M; Thung SN
    Mod Pathol; 2000 Dec; 13(12):1265-8. PubMed ID: 11144921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer.
    Ahrendt SA; Rashid A; Chow JT; Eisenberger CF; Pitt HA; Sidransky D
    J Hepatobiliary Pancreat Surg; 2000; 7(4):426-31. PubMed ID: 11180865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoplastic Transformation of the Peribiliary Stem Cell Niche in Cholangiocarcinoma Arisen in Primary Sclerosing Cholangitis.
    Carpino G; Cardinale V; Folseraas T; Overi D; Grzyb K; Costantini D; Berloco PB; Di Matteo S; Karlsen TH; Alvaro D; Gaudio E
    Hepatology; 2019 Feb; 69(2):622-638. PubMed ID: 30102768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
    Zen Y; Quaglia A; Heaton N; Rela M; Portmann B
    Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Timmer MR; Beuers U; Fockens P; Ponsioen CY; Rauws EA; Wang KK; Krishnadath KK
    Inflamm Bowel Dis; 2013 Jul; 19(8):1789-97. PubMed ID: 23615529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulators of apoptosis in cholangiocarcinoma.
    Jhala NC; Vickers SM; Argani P; McDonald JM
    Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
    Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?].
    Margalit M; Elinav H; Goldin E; Ilan Y
    Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
    Bergquist A; Broomé U
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Ahrendt SA; Eisenberger CF; Yip L; Rashid A; Chow JT; Pitt HA; Sidransky D
    J Surg Res; 1999 Jun; 84(1):88-93. PubMed ID: 10334895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53 in adenocarcinoma of the gallbladder and bile ducts.
    Washington K; Gottfried MR
    Liver; 1996 Apr; 16(2):99-104. PubMed ID: 8740842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis.
    Martins EB; Fleming KA; Garrido MC; Hine KR; Chapman RW
    Gastroenterology; 1994 Aug; 107(2):537-42. PubMed ID: 8039630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation.
    Boberg KM; Jebsen P; Clausen OP; Aabakken L; Brekke I; Schrumpf E
    J Hepatol; 2003 Sep; 39(3):453. PubMed ID: 12927935
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes.
    Hughes NR; Pairojkul C; Royce SG; Clouston A; Bhathal PS
    J Clin Pathol; 2006 Oct; 59(10):1073-8. PubMed ID: 16679351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.